We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Cambridge Nutritional Sciences Plc | LSE:CNSL | London | Ordinary Share | GB00B1VCP282 | ORD 4P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 3.75 | 869,882 | 01:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 3.50 | 4.00 | 3.75 | 3.75 | 3.75 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Offices-holdng Companies,nec | 8.19M | -3.86M | -0.0162 | -2.31 | 8.91M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 16:27:03 | O | 221,037 | 3.622 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 25/7/2024 | 07:00 | UK RNS | Cambridge Nutritional Sciences PLC Final Results |
| 10/7/2024 | 07:00 | UK RNS | Cambridge Nutritional Sciences PLC Notice of Results |
| 06/6/2024 | 16:26 | UK RNS | Cambridge Nutritional Sciences PLC Grant of Options |
| 24/5/2024 | 20:19 | ALNC |  IN BRIEF: Cambridge Nutritional Sciences appoints James Copper as COO |
| 24/5/2024 | 07:00 | UK RNS | Cambridge Nutritional Sciences PLC Directorate Change |
| 22/4/2024 | 10:09 | ALNC | Cambridge Nutritional Sciences shares jump on expected revenue boost |
| 22/4/2024 | 08:21 | UK RNS | Cambridge Nutritional Sciences PLC Trading Update and Directorate Change |
| 03/4/2024 | 07:00 | UK RNS | Cambridge Nutritional Sciences PLC Q2 2024 Industry Events Schedule |
| 30/1/2024 | 12:50 | UK RNS | Cambridge Nutritional Sciences PLC Issue of Equity and Total Voting Rights |
| 29/1/2024 | 21:25 | ALNC | IN BRIEF: Cambridge Nutritional Sciences hires first operations chief |
Cambridge Nutritional Sc... (CNSL) Share Charts1 Year Cambridge Nutritional Sc... Chart |
|
1 Month Cambridge Nutritional Sc... Chart |
Intraday Cambridge Nutritional Sc... Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 26/7/2024 | 07:27 | Cambridge Nutritional Sciences: Ex Omega Diagnostics (ODX) | 347 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 2024-07-26 15:47:54 | 3.62 | 221,037 | 8,005.96 | O |
| 2024-07-26 15:27:04 | 3.55 | 9,623 | 341.62 | O |
| 2024-07-26 14:46:23 | 3.92 | 102 | 4.00 | O |
| 2024-07-26 13:54:22 | 3.62 | 1,258 | 45.56 | O |
| 2024-07-26 13:32:55 | 3.66 | 9,500 | 347.23 | O |
| Top Posts |
|---|
Posted at 26/7/2024 09:20 by Cambridge Nutritional Sc... Daily Update Cambridge Nutritional Sciences Plc is listed in the Offices-holdng Companies,nec sector of the London Stock Exchange with ticker CNSL. The last closing price for Cambridge Nutritional Sc... was 3.75p.Cambridge Nutritional Sc... currently has 237,685,180 shares in issue. The market capitalisation of Cambridge Nutritional Sc... is £8,913,194. Cambridge Nutritional Sc... has a price to earnings ratio (PE ratio) of -2.31. This morning CNSL shares opened at 3.75p |
Posted at 25/7/2024 07:31 by kingston78 Excellent results at all fronts. £5.4 million cash. That is amazing. Share price should rise substantially to reflect the true value of the business. |
Posted at 23/7/2024 08:02 by thecoyone The level of bashing of this company is very poor, presumably the above poster is the same entity that said on LSE the company would burn cash this FY, instead the cash position increased to £5.4m !The market is forward looking, as such the forward looking statement in the results due on Thursday will drive the share price Yes 6p to 8p is my near term target price range, still some way from 12p a share last broker target. |
Posted at 22/7/2024 09:56 by kingston78 The share price will double to 8 p soon on good results,presentation and broker's upgrade. |
Posted at 19/7/2024 12:31 by silverspoon2009 Well from what I can see there is very little stock on offer once again ahead of the results next week.With only 237m share issued the free float is tiny, a fair bet would be the share price hitting 5p PDQ and moving into a more established 7p-8p range, with all this positivity coming from the company it has to be worth a fat lot more than £9.5m. Yes those broker targets were 10p to 12p a share. |
Posted at 19/7/2024 08:42 by kingston78 Recently there have been large volumes of trading in some hot small cap stocks, pushing some of them up by over 100% or more quickly.The share chart of CNSL is rising again, and if the mid-price at 4 p holds the share will push upwards towards 5 and 6 p quickly. A barrier is difficult to break, but once broken, there is a quantum leap. I hope that the share price after the announcement of result and investors presentation will double to 8 p. I have also noticed that some traders rotate by targeting to push up one or two stocks and then hunt another target. I hope that they will land on here to push up the share price of CNSL. |
Posted at 13/5/2024 12:17 by yasxii Gentlemen.I am mindful to contact the house broker Cavendish seeking an explanation as to why they continue to have their share price target as 'under review' Whilst the Gracious Fellow takes little notice of broker 'targets' many do, their last proposition suggested the Health & Nutrition business was worthy of 10p a share alone. Failure to deliver an updated target price is clearly due to abject laziness, nothing else. It is worth noting their recent update was exceptionally bullish, well so be it, give the market a valuation viewpoint then. The matter will also be raised at the next Q&A session. In the meantime fill your boots with CNSL stock. |
Posted at 22/4/2024 21:56 by wbodger Understandable they want a premium for 150,000 shares - CNSL could be a bid target and there are only 237 million shares in issue. I'm surprised there is any market at 3.7p at all, mid price, because that only equates to a £9 million market cap. That's derisory.If Cavendish can't get the share price higher shame on them. The LSE is in trouble because financial advisors and Nomads get paid for getting companies sold at stupid prices. That's the clear danger here - lowball takeover. Companies that don't buy back their own shares when they are under shorting attack get taken over for peanuts. CNSL has cash, if their advisor thinks market cap should be £23 million use some of the cash to buy back shares. That's what I do if I can buy £10 notes for a fiver. |
Posted at 22/4/2024 12:21 by thecoyone My understanding is it is being strongly contested and CNSL have also put in what they describe as a very significant counter claim.CNSL legal advice implies they have no liability to repay it, on the contrary in fact. The Gov have not been responding to CNSL so that in itself is a sign they (the Gov) are potentially liable to pay damages, I have followed this matter extensively. So far the new team at CNSL have hardly put a foot out of place. |
Posted at 14/3/2024 08:11 by thecoyone Results today from Abingdon Health show the sector is returning back to health, this has to be good for all participants, especially the smaller companies whose share prices have been battered down.I think CNSL is one of the best plays for capital appreciation in the sector starting from a very low base, their cash position is exceptional around £4m, how many AIM listed outfits would like that number in their bank. If all goes to plan I expect to see the share price above 10p by year end, my only concern, as mentioned before, is a low ball takeover approach but the BOD have stated it would need to be at a significant premium to market to be considered. Fact is the shares are cheap (£6.5m m/cap), very cheap, no wonder it is very difficult to get a meaningful slice. |
Posted at 12/3/2024 15:04 by one2go Not seen YasXII for a while but this post was from December, he is a strong bull of CNSLyasXII - 11 Dec 2023 - 14:47:52 - 73 of 112 Cambridge Nutritional Sciences - CNSL Remember fools and money are easily parted, some may be happy with a modest trading profit but the real money is made by the patient. The Gracious Fellow draws attention to a fair period of share price consolidation over recent weeks but the prudent are buyers in a thin market. Get ready for the next move north, it could be spectacular, some may be happy with 5p a share however that is a minimum view for the experienced eye. Who wants to join the Gracious One on the next ride up ?? |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
